Aldo M. Roccaro is a Senior Scientist at Harvard Medical School, Boston, Mass, USA. He completed his M.D. degree at Bari Medical School, Bari, Italy, and joined the Dana-Farber Cancer Institute as a Postdoctoral Fellow in 2004. Prior to this, he was a Fellow in hematology/oncology at the University of Bari, Bari, Italy; and at the Unit of Blood Diseases and Cell Therapies, University of Brescia Medical School, Brescia, Italy. Dr. Roccaro’s research mainly focuses on B-cell malignancies. His specific areas of interests are neoangiogenesis in Multiple Myeloma (MM) and Waldenstrom’s Macroglobulinemia (WM). He has been recently pioneering work on microRNAs in WM and MM, contributing to major advances in understanding the role of epigenetic modification that leads to the initiation and progression of MM and WM. Dr. Roccaro is a recipient of several awards from the Italian Association for Cancer Research, Berlucchi Foundation, the American Society of Hematology (ASH), the European Hematology Association (EHA), The Doctors’ Cancer Foundation, Claudia Adams Barr, and Accademia Nazionale dei Lincei. Under the mentorship of extremely well-known experts in the field of WM and MM (Drs. F. Dammacco, A. Vacca, K.C. Anderson, I.M. Ghobrial, and S.P. Treon), he has authored more than 90 manuscripts in peer-reviewed literature and has written nine chapters in hematology/oncology textbooks. He also contributed to the English-to-Italian translation of the Netter’s Clinical Anatomy.
Biography Updated on 20 October 2015